BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261206
DTEND;VALUE=DATE:20261209
DTSTAMP:20260915T123240Z
CREATED:20260915T123240Z
LAST-MODIFIED:20260915T123240Z
UID:10001033-1796515200-1796774399@oncodaily.com
SUMMARY:AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer
DESCRIPTION:The AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer will take place from December 6–8\, 2026\, at the Hyatt Regency Austin in Austin\, Texas\, USA. \nOrganized by the American Association for Cancer Research (AACR)\, the conference will bring together basic scientists\, physician-scientists\, and industry professionals to discuss advances in liver cancer biology and treatment. \nThe program will cover the molecular pathogenesis and risk factors of hepatocellular carcinoma\, immunotherapy across early-\, intermediate-\, and advanced-stage HCC\, cholangiocarcinoma\, tumor microenvironment\, immune modulation\, microbiome\, predictive biomarkers\, liquid biopsy\, clinical trial design\, and emerging therapeutic combinations. Sessions will also address health disparities\, pediatric liver tumors\, and the patient advocacy perspective.
URL:https://oncodaily.com/event/aacr-special-conference-586479
LOCATION:Hyatt Regency Austin\, 208 Barton Springs Road\, Austin\, Texas\, 78704\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/images-30-1.webp
ORGANIZER;CN="American Association for Cancer Research (AACR)":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261207T120000
DTEND;TZID=America/Halifax:20261207T130000
DTSTAMP:20260921T160846Z
CREATED:20260921T160846Z
LAST-MODIFIED:20260921T160846Z
UID:10001058-1796644800-1796648400@oncodaily.com
SUMMARY:SITC Computational Immuno-Oncology – Pre-Cancer Atlas
DESCRIPTION:The SITC Computational Immuno-Oncology – Pre-Cancer Atlas webinar will take place on December 7\, 2026\, from 12:00–1:00 PM ET\, online. \nOrganized by the Society for Immunotherapy of Cancer (SITC) Big Data and Data Sharing Committee\, the session is part of the 2026 Computational Immuno-Oncology Webinar Series. Society for Immunotherapy of Cancer \nThe webinar will focus on the Pre-Cancer Atlas within a series exploring advanced computational and AI-enabled approaches in immuno-oncology. The broader series emphasizes biomarker development\, early-disease settings\, immunoprevention\, immune interception\, patient stratification\, and therapeutic optimization.
URL:https://oncodaily.com/event/pre-cancer-atlas-590870
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/image-2-24-e1743178337816-2.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261208
DTEND;VALUE=DATE:20261212
DTSTAMP:20260808T153556Z
CREATED:20260808T153556Z
LAST-MODIFIED:20260808T153556Z
UID:10000885-1796688000-1797033599@oncodaily.com
SUMMARY:SABCS 2026: 49th Annual San Antonio Breast Cancer Symposium
DESCRIPTION:The San Antonio Breast Cancer Symposium (SABCS) 2026 will take place on 8–11 December 2026 at the Henry B. González Convention Center in San Antonio\, Texas\, with both in-person and virtual participation available. \nThe symposium brings together more than 11\,000 physicians\, researchers\, clinicians\, and patient advocates from over 100 countries\, making it one of the world’s largest meetings dedicated to breast cancer. \nThe scientific programme spans the full spectrum of breast cancer research\, including experimental biology\, etiology\, translational science\, prevention\, diagnosis\, treatment\, and late-breaking clinical trials\, with scientific sessions\, poster presentations\, exhibitions\, networking opportunities\, satellite educational symposia\, and continuing education activities. \nEarly registration is available through 25 September 2026\, with in-person rates starting at $835 for regular attendees\, $665 for AACR members\, $215 for residents/postdoctoral fellows\, $325 for nurses\, $85 for students\, and $75 for patient advocates. Recorded sessions will also be available on demand after the meeting.
URL:https://oncodaily.com/event/sabcs-562348
LOCATION:Henry B. González Convention Center\, 900 E Market Street\, San Antonio\, TX\, 78205\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-8-2026-07_34_35-PM.webp
ORGANIZER;CN="The San Antonio Breast Cancer Symposium":MAILTO:sabcs@uthscsa.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261210
DTEND;VALUE=DATE:20261212
DTSTAMP:20260721T134227Z
CREATED:20260721T134201Z
LAST-MODIFIED:20260721T134227Z
UID:10000807-1796860800-1797033599@oncodaily.com
SUMMARY:ESSO's Hands-on Course on Thyroid Cancer Surgery
DESCRIPTION:The Level 1 Hands-on Course on Thyroid Cancer Surgery\, organized by the European Society of Surgical Oncology (ESSO)\, will take place on 10–11 December 2026 in Halle (Saale)\, Germany. \nThe first day will be held at Universitätsklinikum Halle and will feature expert lectures\, live surgery\, clinical case discussions\, and updates on differentiated\, medullary\, advanced\, and recurrent thyroid cancer. The second day\, hosted at the Institut für Anatomie und Zellbiologie\, will focus on hands-on cadaveric training in central and lateral neck dissection techniques. The course is intended for young surgeons and surgical trainees interested in thyroid surgery.
URL:https://oncodaily.com/event/thyroid-cancer-surgery-547652
LOCATION:Universitätsklinikum Halle\, Ernst-Grube-Strasse 40\, Halle (Saale)\, Saxony-Anhalt\, 06120\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/44b24fc5965b4cdfbccf334542c42a60.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261210
DTEND;VALUE=DATE:20261213
DTSTAMP:20260812T192306Z
CREATED:20260812T192306Z
LAST-MODIFIED:20260812T192306Z
UID:10000902-1796860800-1797119999@oncodaily.com
SUMMARY:Paris Colon Cancer Congress 2026
DESCRIPTION:The Paris Colon Cancer Congress 2026 (P3C)\, organized by the Young Oncologist in GI Group – Europe\, part of the OncoDaily ecosystem\, will take place on 10–12 December 2026. \nThe international congress will bring together colorectal cancer specialists\, multidisciplinary care teams\, researchers\, healthcare professionals\, patient advocates\, and leaders to advance evidence-based and patient-centered colorectal cancer care. \nThe programme will address early-onset\, localized\, and metastatic colorectal cancer\, including immunotherapy\, biomarkers\, treatment sequencing\, survivorship\, quality of life\, equity\, access to care\, and multidisciplinary decision-making. Through expert sessions\, clinical debates\, multidisciplinary discussions\, and patient perspectives\, P3C will provide a platform to examine challenging areas of practice and emerging evidence while supporting practical strategies to improve outcomes worldwide. \nScientific leadership includes Julien Taieb\, Annalice Gandini\, Amalya Sargsyan\, and Francisco Javier Ros. \nRegister Now.
URL:https://oncodaily.com/event/colon-cancer-congress-565144
LOCATION:Paris\, Paris\, Île-de-France\, France
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/bc9e7d20-e238-4154-b2f4-73fb61994265-1.webp
ORGANIZER;CN="Young Oncologist in GI Group %E2%80%93 Europe":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261210T120000
DTEND;TZID=America/Halifax:20261210T130000
DTSTAMP:20260901T211405Z
CREATED:20260901T211306Z
LAST-MODIFIED:20260901T211405Z
UID:10000982-1796904000-1796907600@oncodaily.com
SUMMARY:Lunchtime Best Oncology Practice Series: Billing and Coding Update
DESCRIPTION:The “Lunchtime Best Oncology Practice Series: Billing and Coding Update\,” organized by the Northern New England Clinical Oncology Society (NNECOS)\, will take place on December 10\, 2026\, from 12:00 PM to 1:00 PM EST (9:00–10:00 PM AMT) as a virtual webinar. \nThe interactive session will help oncology practices prepare for billing and coding changes taking effect in the new year\, covering potential topics such as new and revised CPT codes\, reimbursement and payer-policy updates\, documentation strategies\, and coding considerations specific to oncology nursing and navigation practice. \nThe programme will be shaped in part by questions and priorities submitted by attendees. Rachael Willeford\, CPB\, CHONC\, Senior Coverage and Reimbursement Specialist in the Care Delivery Department at the American Society of Clinical Oncology (ASCO)\, will present the session.
URL:https://oncodaily.com/event/best-oncology-practice-579167
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-27-2026-04_30_53-PM.webp
ORGANIZER;CN="Northern New England Clinical Oncology Society (NNECOS)":MAILTO:info@nnecos.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261211
DTEND;VALUE=DATE:20261214
DTSTAMP:20260921T153052Z
CREATED:20260921T153052Z
LAST-MODIFIED:20260921T153052Z
UID:10001053-1796947200-1797206399@oncodaily.com
SUMMARY:11th Mayo Clinic Symposium on Immuno-Oncology and Tumor Microenvironment Crosstalk 2026
DESCRIPTION:The 11th Mayo Clinic Symposium on Immuno-Oncology and Tumor Microenvironment Crosstalk 2026 will take place from December 11–13\, 2026\, at Mayo Clinic in Jacksonville\, Florida\, USA\, with livestream participation available. \nOrganized by Mayo Clinic College of Medicine and Science\, the symposium will bring together researchers and clinicians to discuss advances in immuno-oncology\, tumor biology\, and the interactions between cancer and the tumor microenvironment. \nThe program will explore tumor microenvironment biology\, cancer immunology\, immunotherapy\, translational research\, diagnostics\, nanotechnology\, and emerging therapeutic approaches. The symposium is designed to encourage interaction between basic scientists and clinical investigators while examining how discoveries in tumor biology and immune regulation can be translated into new strategies for cancer treatment. \n 
URL:https://oncodaily.com/event/tumor-microenvironment-crosstalk-590833
LOCATION:Mayo Clinic Jacksonville – Cannaday Building\, Kinne Auditorium\, 4500 San Pablo Road\, Jacksonville\, FL\, 32224\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-21-2026-07_22_48-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261211T070000
DTEND;TZID=America/Halifax:20261211T100000
DTSTAMP:20261002T203817Z
CREATED:20261002T203817Z
LAST-MODIFIED:20261002T203817Z
UID:10001085-1796972400-1796983200@oncodaily.com
SUMMARY:ASH – Friday Satellite Symposium
DESCRIPTION:The ASH – Friday Satellite Symposium: A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes\, Activators\, and Beyond will take place on December 11\, 2026\, at the New Orleans Ernest N. Morial Convention Center (MCCNO) in New Orleans\, Louisiana\, USA.  \nThe symposium is part of the 2026 ASH Friday Satellite Symposia\, which are industry-supported\, CME-accredited educational sessions held the day before the ASH Annual Meeting. ASH notes that these symposia are separate from the official ASH Annual Meeting programme and are planned by the organizing company. \nThis live 90-minute symposium will focus on the rapidly evolving treatment landscape for sickle cell disease (SCD). The programme will examine clinically relevant differences among approved and emerging gene therapies\, as well as current evidence surrounding pyruvate kinase (PK) activators and their potential integration into clinical practice. \nThrough case-based discussions and interaction with expert faculty\, the session will address how clinicians can match emerging treatment approaches to individual patient profiles and facilitate timely referrals to qualified treatment centres.
URL:https://oncodaily.com/event/friday-satellite-symposium-599277
LOCATION:New Orleans Ernest N. Morial Convention Center (MCCNO)\, Hall C\, 900 Convention Center Boulevard\, New Orleans\, LA\, 70130\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/ash-ff-1-e1733412950524-800x450-1-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261212
DTEND;VALUE=DATE:20261214
DTSTAMP:20260920T200621Z
CREATED:20260920T200621Z
LAST-MODIFIED:20260920T200621Z
UID:10001051-1797033600-1797206399@oncodaily.com
SUMMARY:Diagnostic Excellence Across the Cancer Care Continuum: Screening\, Early Detection\, Complications and Survivorship
DESCRIPTION:The Diagnostic Excellence Across the Cancer Care Continuum: Screening\, Early Detection\, Complications and Survivorship will take place on December 12–13\, 2026\, at Memorial Sloan Kettering Cancer Center (MSK) in New York City\, USA\, with virtual and on-demand participation available. \nThe program is organized by Memorial Sloan Kettering Cancer Center and focuses on improving diagnostic approaches across the entire cancer care pathway. \nThis multidisciplinary educational program will explore advances in cancer screening\, early detection\, diagnostic pathways\, treatment-related complications\, and survivorship care. \nSessions will address topics including optimizing screening strategies\, improving diagnostic accuracy\, evaluation of incidental findings\, reducing diagnostic delays\, managing complications after cancer treatment\, and supporting long-term survivorship care. The course is designed for clinicians and healthcare professionals involved in improving cancer outcomes through earlier and more accurate diagnosis.
URL:https://oncodaily.com/event/cancer-care-continuum-590296
LOCATION:Memorial Sloan Kettering Cancer Center\, 1275 York Avenue\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-21-2026-12_05_38-AM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261212
DTEND;VALUE=DATE:20261216
DTSTAMP:20260808T151858Z
CREATED:20260808T151858Z
LAST-MODIFIED:20260808T151858Z
UID:10000884-1797033600-1797379199@oncodaily.com
SUMMARY:The 68th ASH Annual Meeting and Exposition
DESCRIPTION:The 68th ASH Annual Meeting and Exposition\, organized by the American Society of Hematology (ASH)\, will take place on 12–15 December 2026 at the Ernest N. Morial Convention Center in New Orleans\, Louisiana\, with both in-person and virtual participation available. \nDescribed by ASH as the world’s largest and most comprehensive hematology meeting\, the conference will feature hundreds of sessions presenting the latest research and clinical practice developments across hematology\, including the Education Program\, Scientific Program\, Marquee Sessions\, oral and poster presentations\, special-interest sessions\, exhibits\, and industry-related activities. \nMost in-person sessions will also be broadcast live through the virtual platform and available on demand. Advance registration closes on 21 October 2026; standard advance rates include $900 for active/international ASH members\, $1\,700 for nonmembers\, $175 for student/resident members\, $275 for nonmembers in training\, and $800 for allied health professionals\, with optional extended virtual access available for an additional fee.
URL:https://oncodaily.com/event/68th-ash-annual-meeting-562343
LOCATION:Ernest N. Morial Convention Center\, 900 Convention Center Boulevard\, New Orleans\, LA\, 70130\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-8-2026-07_17_46-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261214
DTEND;VALUE=DATE:20261217
DTSTAMP:20251211T194040Z
CREATED:20251211T193956Z
LAST-MODIFIED:20251211T194040Z
UID:10000476-1797206400-1797465599@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2026
DESCRIPTION:The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO)\, scheduled for December 14–16\, 2026\, as an onsite event in London\, United Kingdom\, with an online option also available. \nThe congress serves as a critical platform for exchanging knowledge and fostering collaboration in immuno-oncology\, covering the entire spectrum of the field from basic science to translational research and clinical development. The meeting will feature the latest scientific advances\, offering researchers\, clinicians\, and other stakeholders excellent opportunities to interact\, share expertise\, and engage with the global community committed to advancing cancer care through innovation.
URL:https://oncodaily.com/event/immuno-oncology-426416
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-IO-2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270107
DTEND;VALUE=DATE:20270111
DTSTAMP:20260802T152658Z
CREATED:20260802T152658Z
LAST-MODIFIED:20260802T152658Z
UID:10000851-1799280000-1799625599@oncodaily.com
SUMMARY:AACR Special Conference in Cancer Research: Cancer Biology-informed Radioligand Therapy
DESCRIPTION:The AACR Special Conference in Cancer Research: Cancer Biology-Informed Radioligand Therapy\, organized by the American Association for Cancer Research (AACR) in association with the Cancer Molecular Imaging and Theranostics Task Force\, will take place on 7–10 January 2027 at the Hilton San Diego Bayfront in San Diego\, California. \nThe conference will bring together experts in cancer biology\, immunotherapy\, radiochemistry\, nuclear physics\, radiation biology\, and radioligand therapy to examine how systemic beta- and alpha-emitting isotopes interact with tumors\, the tumor microenvironment\, and the immune system. Sessions will also explore radiotheranostics\, novel isotopes\, repurposed radioligand therapies\, and combinations with targeted therapies\, cellular treatments\, immunotherapy\, and external-beam radiation. The abstract submission deadline is 21 October 2026 at 1:00 p.m. ET.
URL:https://oncodaily.com/event/radioligand-therapy-557645
LOCATION:Hilton San Diego Bayfront\, 1 Park Boulevard\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/1784567962732.webp
ORGANIZER;CN="American Association for Cancer Research (AACR)":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270113
DTEND;VALUE=DATE:20270115
DTSTAMP:20260905T150053Z
CREATED:20260905T150053Z
LAST-MODIFIED:20260905T150053Z
UID:10000995-1799798400-1799971199@oncodaily.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2027
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on January 13–14\, 2027\, in Hong Kong SAR\, China. \nThe two-day educational course will provide a multidisciplinary update on the management of prostate cancer\, covering the disease continuum from diagnosis and risk assessment through localized and advanced disease. \nESMO prostate cancer preceptorships are structured around current standards of care\, multidisciplinary decision-making\, systemic and local treatment strategies\, emerging therapeutic targets\, and future perspectives\, combining expert lectures with practical clinical discussion. The meeting takes place immediately before the inaugural ESMO Genitourinary Cancers Asia 2027\, which begins in Hong Kong on January 15.
URL:https://oncodaily.com/event/preceptorship-on-prostate-cancer-581173
LOCATION:Hong Kong\, Hong Kong\, Hong Kong SAR\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-5-2026-06_58_44-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270114
DTEND;VALUE=DATE:20270118
DTSTAMP:20260802T220412Z
CREATED:20260802T220346Z
LAST-MODIFIED:20260802T220412Z
UID:10000852-1799884800-1800230399@oncodaily.com
SUMMARY:AACR Special Conference in Cancer Research: Redefining Lung Cancer
DESCRIPTION:The AACR Special Conference in Cancer Research: Redefining Lung Cancer—From Mechanistic Biology to Emerging and AI-Driven Therapies\, organized by the American Association for Cancer Research (AACR) in association with the AACR Lung Cancer Task Force\, will take place on 14–17 January 2027 at the Hilton San Diego Bayfront in San Diego\, California. \nThis inaugural Lung Cancer Task Force meeting will bring together researchers\, clinicians\, and innovators to address major challenges across lung cancer prevention\, risk assessment\, early detection\, translational research\, and treatment. The programme will cover minimal residual disease\, immuno-oncology\, oncogene-driven lung cancer\, small cell lung cancer\, resistance mechanisms\, precision medicine\, clinical trial innovation\, genomics\, and artificial intelligence. The abstract submission deadline is 29 October 2026 at 1:00 p.m. ET.
URL:https://oncodaily.com/event/conference-in-cancer-research-557974
LOCATION:Hilton San Diego Bayfront\, 1 Park Boulevard\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/04/AACR-congress-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270117
DTSTAMP:20260818T160212Z
CREATED:20260818T160038Z
LAST-MODIFIED:20260818T160212Z
UID:10000933-1799971200-1800143999@oncodaily.com
SUMMARY:The ESSO-KBCS Course on Minimally Invasive Breast Surgery
DESCRIPTION:The ESSO-KBCS Course on Minimally Invasive Breast Surgery (MIBS) will take place on 15–16 January 2027 in Dubai\, United Arab Emirates. Organized by the European Society of Surgical Oncology (ESSO) in collaboration with KBCS\, this Level 2\, in-person course provides advanced training in minimally invasive breast surgery\, with a focus on robotic and endoscopic nipple-sparing mastectomy with immediate reconstruction. \nThe program covers patient selection\, oncological safety\, robotic and endoscopic surgical techniques\, reconstruction strategies\, complication management\, outcomes\, and development of minimally invasive breast surgery curricula. \nEducational methods include plenary lectures\, video presentations\, live surgery transmission\, demonstration sessions\, small-group workshops\, and interactive discussions. The course is aimed at breast surgery residents\, surgeons in training\, specialty doctors working in breast surgery\, general surgeons with a breast surgery interest\, and other surgical specialists interested in developing skills in minimally invasive breast surgery. Registration is currently open. \nRegister Now.
URL:https://oncodaily.com/event/esso-kbcs-course-569449
LOCATION:American Hospital Dubai\, 12 American Hospital – 15th St – Oud Metha\, Dubai\, Dubai\, United Arab Emirates
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-18-2026-07_50_29-PM.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270118
DTSTAMP:20260826T143152Z
CREATED:20260826T143152Z
LAST-MODIFIED:20260826T143152Z
UID:10000963-1799971200-1800230399@oncodaily.com
SUMMARY:The Inaugural ESMO Genitourinary Cancers Asia 2027
DESCRIPTION:The Inaugural ESMO Genitourinary Cancers Asia 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on January 15–17\, 2027\, at the Kerry Hotel Hong Kong in Hong Kong SAR\, China. \nThe new congress is dedicated to advancing genitourinary oncology across the Asia-Pacific region\, bringing together regional and international experts for multidisciplinary discussion and presentation of practice-changing research. \nThe scientific programme will cover prostate\, bladder\, kidney\, testicular\, and other genitourinary cancers\, with a focus on clinically relevant evidence\, regional perspectives\, research collaboration\, and innovation in GU cancer care. Abstract submission is open until October 13\, 2026\, and registration is now open\, with the early registration deadline on November 11\, 2026.
URL:https://oncodaily.com/event/esmo-genitourinary-cancers-asia-575063
LOCATION:Kerry Hotel Hong Kong\, 38 Hung Luen Road\, Hung Hom Bay\, Kowloon\, Hong Kong\, Kowloon\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-06_31_15-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270118
DTSTAMP:20260930T221029Z
CREATED:20260930T221029Z
LAST-MODIFIED:20260930T221029Z
UID:10001084-1799971200-1800230399@oncodaily.com
SUMMARY:3rd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care
DESCRIPTION:The 3rd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will take place on 15–17 January 2027. \nThe conference will bring together medical oncologists\, hematologists\, radiation oncologists\, and other healthcare professionals for evidence-based educational sessions focused on the latest advances in cancer diagnosis and multidisciplinary management. \nThe program will cover emerging approaches in cancer care\, including precision oncology\, genomics\, artificial intelligence\, immunotherapy\, targeted therapies\, cell and gene therapies\, supportive care\, and challenging clinical case discussions across multiple cancer types. The conference is designed for physicians\, fellows\, residents\, pharmacists\, researchers\, advanced practice providers\, nurses\, and other professionals involved in cancer prevention\, diagnosis\, and treatment.
URL:https://oncodaily.com/event/cleveland-clinic-597838
LOCATION:Omni Hotel\, Fort Lauderdale\, Florida\, 1850 SE 17th Street\, Fort Lauderdale\, FL\, Fort Lauderdale\, FL\, 33316\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/Gemini_Generated_Image_urufgnurufgnuruf.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270119
DTEND;VALUE=DATE:20270121
DTSTAMP:20260927T165758Z
CREATED:20260927T165758Z
LAST-MODIFIED:20260927T165758Z
UID:10001071-1800316800-1800489599@oncodaily.com
SUMMARY:EACR – Mechanisms of Cancer Avoidance: From Cells to Communities
DESCRIPTION:The EACR – Mechanisms of Cancer Avoidance: From Cells to Communities virtual conference will take place from January 19–20\, 2027\, online. \nOrganized by the European Association for Cancer Research (EACR)\, the conference will bring together researchers from cancer biology\, immunology\, epidemiology\, and prevention fields to explore why some individuals and tissues remain cancer-free despite high-risk conditions. \nThe meeting will focus on the emerging field of cancer avoidance\, investigating the biological mechanisms that provide natural resistance to cancer development. Topics will include immune surveillance\, cancer resistance mechanisms\, autoantibody biology\, cancer-free high-risk populations\, ageing and cancer biology\, biomarker discovery\, and prevention strategies. \nThe conference will explore insights from exceptional populations\, including individuals exposed to cancer risk factors who do not develop cancer\, centenarians without malignancy\, and individuals with genetic predispositions who remain cancer-free. Researchers will discuss how understanding these protective mechanisms could contribute to new approaches in cancer prevention and early intervention. \n 
URL:https://oncodaily.com/event/cancer-avoidance-595330
LOCATION:WorldWide
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-27-2026-08_57_11-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270121
DTEND;VALUE=DATE:20270124
DTSTAMP:20260727T151819Z
CREATED:20260727T151819Z
LAST-MODIFIED:20260727T151819Z
UID:10000837-1800489600-1800748799@oncodaily.com
SUMMARY:ASCO GI Cancers Symposium 2027
DESCRIPTION:The 2027 ASCO GI Cancers Symposium\, organized by the American Society of Clinical Oncology (ASCO)\, will take place on 21–23 January 2027 at Moscone West in San Francisco\, California. \nHeld under the theme “Navigating the Path from Innovation to Implementation\,” the symposium will present multidisciplinary advances in gastrointestinal cancer research and care\, covering cancers of the esophagus\, stomach\, pancreas\, small bowel\, hepatobiliary tract\, colon\, rectum\, and anus. \nInternational experts will discuss emerging treatments\, research findings\, clinical innovations\, and strategies for translating scientific progress into everyday practice. Attendees seeking continuing education credit or Maintenance of Certification points must submit their claims through the ASCO Meetings platform by 26 April 2027.
URL:https://oncodaily.com/event/asco-gi-cancers-symposium-552635
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, CA\, 94103\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/asco-1-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270122
DTEND;VALUE=DATE:20270124
DTSTAMP:20260825T224347Z
CREATED:20260825T224347Z
LAST-MODIFIED:20260825T224347Z
UID:10000952-1800576000-1800748799@oncodaily.com
SUMMARY:The 2027 Pan-Africa Conference on Lung Cancer
DESCRIPTION:The 2027 Pan-Africa Conference on Lung Cancer\, organized by the International Association for the Study of Lung Cancer (IASLC)\, will take place on January 22–23\, 2027\, in Nairobi\, Kenya. \nThe conference is part of IASLC’s regional meeting programme and will bring together professionals working in lung cancer and thoracic oncology across Africa and internationally. \nThe Pan-Africa Conference was established to strengthen regional collaboration\, expand access to lung cancer education and research\, and create space for discussions relevant to cancer epidemiology\, access to care\, treatment delivery\, and capacity-building across the African continent. IASLC has confirmed the dates and location\, while the detailed scientific programme\, venue\, registration information\, and other meeting details are still to be announced.
URL:https://oncodaily.com/event/pan-africa-conference-on-lung-cancer-574702
LOCATION:Nairobi\, Nairobi\, Nairobi County\, Kenya
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/lung1.webp
ORGANIZER;CN="International Association for the Study of Lung Cancer (IASCL)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270122
DTEND;VALUE=DATE:20270125
DTSTAMP:20260817T151225Z
CREATED:20260817T151225Z
LAST-MODIFIED:20260817T151225Z
UID:10000924-1800576000-1800835199@oncodaily.com
SUMMARY:The 15th Asia-Pacific Breast Cancer Summit - APBCS 2027
DESCRIPTION:The 15th Asia-Pacific Breast Cancer Summit (APBCS 2027) will take place on 22–24 January 2027 in Singapore. \nThe meeting will mark the 15th edition of APBCS\, bringing together a global community of breast cancer experts and healthcare professionals to exchange perspectives\, discuss advances in breast cancer care\, and strengthen international collaboration. Building on 15 years of scientific exchange\, learning\, innovation\, and professional connections\, APBCS 2027 will focus on the ideas\, discussions\, and developments shaping the future of breast cancer care.
URL:https://oncodaily.com/event/breast-cancer-summit-568471
LOCATION:Grand Hyatt Singapore\, 10 Scotts Road\, Singapore\, Singapore\, 228211\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-17-2026-07_10_39-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270123
DTEND;VALUE=DATE:20270125
DTSTAMP:20260225T073903Z
CREATED:20260225T073903Z
LAST-MODIFIED:20260225T073903Z
UID:10000667-1800662400-1800835199@oncodaily.com
SUMMARY:3rd Annual Hawaii Cancer Conference
DESCRIPTION:The 3rd Annual Hawaii Cancer Conference—incorporating the 5th Annual Hawaii Lung and the 3rd Annual Hawaii Breast Cancer conferences—will be held from January 23–24\, 2027\, at the ‘Alohilani Resort Waikiki Beach in Honolulu. \nLed by co-chairs Dr. David R. Gandara\, Dr. Hope S. Rugo\, Dr. Naoto T. Ueno\, and Dr. Nicolas Villanueva\, this unique event utilizes a 100% case-based format to integrate the expertise of Hawaii-based oncology professionals with mainland US experts. The program is specifically designed for medical\, surgical\, and radiation oncologists\, as well as multidisciplinary teams\, to address the latest therapeutic standards for early-stage and metastatic disease. By focusing on real-world clinical challenges\, the conference empowers practitioners to bring global best practices into their local Hawaii clinics while fostering deep professional collaboration across the islands. \nRegister now.
URL:https://oncodaily.com/event/hawaii-460824
LOCATION:‘Alohilani Resort Waikiki Beach\, 2490 Kalākaua Avenue\, Honolulu\, Hawaii\, 96815\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-25T113942.499.webp
ORGANIZER;CN="Physicians' Education Resource":MAILTO:onc-info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270126
DTEND;VALUE=DATE:20270128
DTSTAMP:20260909T074659Z
CREATED:20260909T074659Z
LAST-MODIFIED:20260909T074659Z
UID:10001001-1800921600-1801094399@oncodaily.com
SUMMARY:2nd Biennale of Specialized Oncology Nurses (BIO 2027)
DESCRIPTION:The 2nd Biennale of Specialized Oncology Nurses (BIO 2027) will take place on January 26–27\, 2027\, at the Monte-Carlo Congress Centre\, Fairmont Monte Carlo\, in Monaco. \nThe two-day meeting is dedicated to oncology nurses\, care coordinators\, consultation nurses\, and advanced practice nurses in oncology\, with a 2027 scientific focus on breast and gastrointestinal cancers. \nThe programme will address HER2-positive and hormone receptor-positive breast cancer\, triple-negative breast cancer\, pancreatic\, colorectal\, gastric and hepatocellular cancers\, radiotherapy updates\, treatment sequencing\, toxicities\, supportive care\, genomic signatures\, hereditary cancer predisposition\, palliative care\, sleep disorders\, sarcopenia\, physical activity\, and communication skills. Small-group workshops and practical sessions are also planned to strengthen clinical reasoning and patient-support skills.
URL:https://oncodaily.com/event/specialized-oncology-nurses-583086
LOCATION:Monte-Carlo Congress Centre\, Fairmont Monte Carlo\, 12 Avenue des Spélugues\, Monte Carlo\, Monaco\, 98000\, Monaco
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/1779278938994.webp
ORGANIZER;CN="Lena Corporation SAM":MAILTO:monaco@lenagroup.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270127
DTEND;VALUE=DATE:20270130
DTSTAMP:20260815T162422Z
CREATED:20260815T162422Z
LAST-MODIFIED:20260815T162422Z
UID:10000916-1801008000-1801267199@oncodaily.com
SUMMARY:The 11th Monaco Age Oncologie - MAO 2027
DESCRIPTION:The 11th Monaco Age Oncologie (MAO 2027) – Cours Francophone d’Oncogériatrie will take place on 27–29 January 2027 at the Monte-Carlo Congress Centre\, Fairmont Monaco\, in Monaco. \nThe meeting will bring together more than 600 healthcare professionals\, including oncologists\, geriatricians\, nurses\, and other specialists involved in the care of older adults with cancer. \nThe multidisciplinary programme will address major updates across organ-specific cancers\, vaccination for patients receiving chemotherapy\, cancer pain management\, nutrition and physical activity throughout the care pathway\, the use of artificial intelligence in older patients\, biological versus chronological aging\, and the future of geriatric oncology. \nThe congress is supported by an international scientific and organizing committee and includes the Michel Hery Prize\, scientific sessions\, expert discussions\, and opportunities for professional exchange. Early-rate registration closes on 29 November 2026\, while online registration closes on 22 January 2027. (mao-monaco.org)
URL:https://oncodaily.com/event/mao-2027-567074
LOCATION:Monte-Carlo Congress Centre\, Fairmont Monte Carlo\, 12 Avenue des Spélugues\, Monte Carlo\, Monaco\, 98000\, Monaco
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-15-2026-08_15_05-PM.webp
ORGANIZER;CN="Monaco Age Oncologie (MAO)":MAILTO:info@mao-monaco.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270128
DTEND;VALUE=DATE:20270201
DTSTAMP:20260802T221327Z
CREATED:20260802T221327Z
LAST-MODIFIED:20260802T221327Z
UID:10000853-1801094400-1801439999@oncodaily.com
SUMMARY:AACR Targeting RAS Conference: Novel Therapies and Clinical Impact
DESCRIPTION:The AACR Conference on Targeting RAS: Novel Therapeutics and Clinical Impact\, organized by the American Association for Cancer Research (AACR)\, will take place on 28–31 January 2027 at the Westin San Diego Bayview in San Diego\, California. \nThe conference will bring together leaders from academia\, industry\, and clinical oncology to examine advances in RAS biology and the rapidly evolving development of direct RAS inhibitors and combination therapies. Sessions will explore structural and chemical biology\, omics\, immunology\, treatment response and resistance\, pathway adaptation\, tumour heterogeneity\, and emerging therapeutic vulnerabilities. The programme will address RAS-driven pancreatic\, colorectal\, lung\, melanoma\, and hematologic malignancies\, while a dedicated session will highlight promising clinical trial findings selected from submitted abstracts. \n 
URL:https://oncodaily.com/event/aacr-557986
LOCATION:The Westin San Diego Bayview\, 1051 Columbia Street\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/04/AACR-congress-1.webp
ORGANIZER;CN="American Association for Cancer Research (AACR)":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270129
DTEND;VALUE=DATE:20270201
DTSTAMP:20260225T074354Z
CREATED:20260225T074317Z
LAST-MODIFIED:20260225T074354Z
UID:10000668-1801180800-1801439999@oncodaily.com
SUMMARY:24th Annual Winter Lung Cancer Conference 2027
DESCRIPTION:The 24th Annual Winter Lung Cancer Conference will be held from January 29–31\, 2027\, at the Fontainebleau Miami Beach. \nChaired by Dr. Julie R. Brahmer\, Dr. Edgardo S. Santos Castillero\, and Dr. Mark A. Socinski\, this milestone meeting provides an interactive\, case-based curriculum focused on resolving the most complex challenges in treatment sequencing and toxicity management. The 2027 agenda features signature Medical Crossfire sessions and multidisciplinary tumor boards\, offering deep dives into perioperative immunotherapy\, novel targeted agents\, and lung cancer screening updates. Designed for medical oncologists and their multidisciplinary teams\, this summit bridges clinical trial data with real-world application to optimize patient outcomes in both early-stage and metastatic disease. \nRegister now.
URL:https://oncodaily.com/event/lung-cancer-460829
LOCATION:Fontainebleau Miami Beach\, 4441 Collins Avenue\, Miami Beach\, Florida\, 33140\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-25T114054.942.webp
ORGANIZER;CN="Physicians' Education Resource":MAILTO:onc-info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20270130T070000
DTEND;TZID=America/Halifax:20270130T123000
DTSTAMP:20260730T160817Z
CREATED:20260730T160817Z
LAST-MODIFIED:20260730T160817Z
UID:10000843-1801292400-1801312200@oncodaily.com
SUMMARY:2027 Wisconsin Official Review of San Antonio Breast Cancer Symposium
DESCRIPTION:The 2027 Wisconsin Official Review of the San Antonio Breast Cancer Symposium\, organized by the Wisconsin Association of Hematology and Oncology (WAHO)\, will take place in person on 30 January 2027 from 7:00 a.m. to 12:30 p.m. CST at The Pfister Hotel in Milwaukee\, Wisconsin. \nThe meeting will bring together oncology professionals from across the state to review important breast cancer research and treatment updates presented at the San Antonio Breast Cancer Symposium. Expert-led discussions will address emerging therapies\, evolving standards of care\, healthcare disparities\, practice-management challenges\, and practical strategies for improving patient outcomes. The event is intended for physicians and multidisciplinary oncology professionals\, including nurses\, pharmacists\, advanced practice providers\, administrators\, social workers\, fellows\, and retirees.
URL:https://oncodaily.com/event/breast-cancer-symposium-555217
LOCATION:The Pfister Hotel\, 424 East Wisconsin Avenue\, Milwaukee\, WI\, 53202\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-30-2026-08_07_02-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270202
DTEND;VALUE=DATE:20270203
DTSTAMP:20260910T221213Z
CREATED:20260910T221213Z
LAST-MODIFIED:20260910T221213Z
UID:10001013-1801526400-1801612799@oncodaily.com
SUMMARY:ESSO Video-Based Workshop on Cytoreductive Surgery
DESCRIPTION:The ESSO Video-Based Workshop on Cytoreductive Surgery will take place on February 2\, 2027\, at the KARL STORZ Visitor and Training Center in Berlin\, Germany\, with online participation also available. \nThis Level 1 workshop will provide a detailed\, video-based review of cytoreductive surgery (CRS) for peritoneal surface malignancies\, covering peritoneal anatomy\, parietal and visceral peritonectomy\, PCI scoring\, minimally invasive CRS\, visceral resections\, reconstruction\, abdominal closure\, and operative reporting. \nThe programme combines surgical video demonstrations with expert discussion\, panel sessions\, and interactive Q&A\, and is aimed at senior surgical residents and experienced consultant surgeons seeking to refine their technical understanding of CRS.
URL:https://oncodaily.com/event/cytoreductive-surgery-584057
LOCATION:KARL STORZ Visitor and Training Center Berlin\, Scharnhorststraße 3\, Berlin\, Berlin\, 10115\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-11-2026-02_02_29-AM.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270203
DTEND;VALUE=DATE:20270205
DTSTAMP:20260929T120000Z
CREATED:20260929T120000Z
LAST-MODIFIED:20260929T120000Z
UID:10001072-1801612800-1801785599@oncodaily.com
SUMMARY:EACR – Induced Proximity: Degradation and Beyond
DESCRIPTION:The EACR – Induced Proximity: Degradation and Beyond virtual conference will take place from February 3–4\, 2027\, online. \nOrganized by the European Association for Cancer Research (EACR)\, the conference will bring together academic and industry experts to explore emerging induced proximity technologies and their applications in cancer drug discovery and treatment development. \nThe meeting will focus on the rapidly evolving field of targeted protein degradation and induced proximity approaches\, including PROTACs\, molecular glue degraders\, novel E3 ligases\, computational discovery strategies\, and next-generation concepts beyond protein degradation. \nThe programme will address both mechanistic and translational aspects of these technologies\, including rational molecule design\, expanding the target space for degraders\, enabling technologies\, and challenges in bringing new proximity-based therapies into clinical development. \n 
URL:https://oncodaily.com/event/induced-proximity-596749
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-29-2026-03_59_12-PM.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270203
DTEND;VALUE=DATE:20270206
DTSTAMP:20260818T161736Z
CREATED:20260818T161736Z
LAST-MODIFIED:20260818T161736Z
UID:10000934-1801612800-1801871999@oncodaily.com
SUMMARY:ESSO Advanced Course on the Management of HIPEC after CRS
DESCRIPTION:The Advanced Course on the Management of HIPEC after CRS\, organized by the European Society of Surgical Oncology (ESSO)\, will take place on February 3–5\, 2027\, in Berlin\, Germany. \nThis Level 1 advanced course focuses on cytoreductive surgery (CRS)\, hyperthermic intraperitoneal chemotherapy (HIPEC)\, and other intraperitoneal treatments for primary and secondary peritoneal malignancies. \nThe multidisciplinary program combines evidence-based clinical decision-making with practical training\, including plenary lectures\, case discussions\, video and live demonstrations\, debates and pro/con sessions\, and a wet-lab where participants can practice open and minimally invasive cytoreductive surgery. Key topics include peritoneal surface malignancies\, colorectal and gastric cancer\, appendiceal cancer and pseudomyxoma peritonei\, mesothelioma\, ovarian cancer\, minimally invasive CRS\, and emerging approaches in peritoneal surface oncology. \nThe course is intended for senior residents\, experienced surgical oncologists\, gastrointestinal and gynecologic oncologists\, and early-career surgeons interested in peritoneal malignancies. Participants may also attend only the theoretical component\, either in person or online. Registration is currently open.
URL:https://oncodaily.com/event/hipec-569464
LOCATION:KARL STORZ SE & Co. KG – Visitor and Training Center\, Scharnhorststrasse 3\, Berlin\, Berlin\, 10115\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-18-2026-08_14_57-PM.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
END:VCALENDAR